• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

    43.18 +1.22 (+2.91%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 989,605
    Open 42.18
    Bid (Size) 40.00 (25)
    Ask (Size) 44.95 (2)
    Prev. Close 41.96
    Today's Range 40.18 - 43.81
    52wk Range 23.41 - 62.58
    Shares Outstanding 58,951,469
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Agios Pharmaceuticals Inc (NASDAQ:AGIO) Tops Q3 2025 Estimates with Strong Revenue Beat
    Agios Pharma's Q3 2025 results beat revenue and EPS estimates, driving a positive market reaction and highlighting strong commercial performance. 
    Via Chartmill
    Earnings Scheduled For October 30, 2025
     
    Via Benzinga

    Performance

    YTD
    +35.6%
    +35.6%
    1 Month
    +7.6%
    +7.6%
    3 Month
    +16.0%
    +16.0%
    6 Month
    +39.6%
    +39.6%
    1 Year
    -6.7%
    -6.7%

    More News

    Read More
    Earnings Outlook For Agios Pharmaceuticals
    Via Benzinga
    Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
    Via MarketMinute
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
    From Pomerantz LLP
    Via GlobeNewswire
    Agios Retail Buzz Surges On Saudi Thalassemia Nod As Retail Hails ‘Incredible Recovery’ Despite FDA Concerns
    Via Stocktwits
    Earnings Scheduled For July 31, 2025
    Via Benzinga
    Earnings Scheduled For May 1, 2025
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm
    From Schall Law Firm
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
    From Pomerantz LLP
    Via GlobeNewswire
    An Overview of Agios Pharmaceuticals's Earnings
    Via Benzinga
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO
    From Pomerantz LLP
    Via GlobeNewswire
    Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More
    Via Stocktwits
    FDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded Use
    Via Benzinga
    Top movers in Thursday's pre-market session
    Via Chartmill
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Traders are paying attention to the gapping stocks in Monday's session.
    Via Chartmill
    What's going on in today's pre-market session
    Via Chartmill
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Agios (AGIO) Q2 Revenue Jumps 45%
    Via The Motley Fool
    Topics Intellectual Property
    Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Mixed Q2 2025 Results: Revenue Beat but Wider EPS Loss
    Via Chartmill
    Agios Pharmaceuticals Reveals Encouraging Data From Rare Blood Disorder Study In Younger Patients Aged Below 18 Years
    Via Benzinga

    Frequently Asked Questions

    Is Agios Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Agios Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Agios Pharmaceuticals, Inc. - Common Stock trade on?
    Agios Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock is AGIO on the Nasdaq Stock Market
    What is the current price of Agios Pharmaceuticals, Inc. - Common Stock?
    The current price of Agios Pharmaceuticals, Inc. - Common Stock is 43.18
    When was Agios Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Agios Pharmaceuticals, Inc. - Common Stock was at 10/30/25 04:00 PM ET
    What is the market capitalization of Agios Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Agios Pharmaceuticals, Inc. - Common Stock is 2.55B
    How many shares of Agios Pharmaceuticals, Inc. - Common Stock are outstanding?
    Agios Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.